Evaluating the economic burden of psoriasis in the United States
Authors:
- 1 June 2015
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 72 (6) , 961-967.e5
Abstract
No abstract availableKeywords
Funding Information
- Novartis Pharmaceuticals Corporation
- National Institute on Aging (P01 AG033559)
This publication has 91 references indexed in Scilit:
- Trends in lipid profiles in patients with psoriasis: a population-based analysisBMC Dermatology, 2012
- Physical and Mental Impact of Psoriasis Severity as Measured by the Compact Short Form-12 Health Survey (SF-12) Quality of Life ToolJournal of Investigative Dermatology, 2012
- Prevalence of the Metabolic Syndrome in PsoriasisArchives of Dermatology, 2011
- Increased Prevalence of the Metabolic Syndrome in Patients with Psoriatic ArthritisMetabolic Syndrome and Related Disorders, 2010
- Skin cancers associated with autoimmune conditions among elderly adultsBritish Journal of Cancer, 2010
- Psoriasis and the Risk of Diabetes and HypertensionArchives of Dermatology, 2009
- Trends in incidence of adult-onset psoriasis over three decades: A population-based studyJournal of the American Academy of Dermatology, 2009
- Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population‐based studyArthritis Care & Research, 2009
- Smoking and the Risk of Psoriasis in Women: Nurses’ Health Study IIThe American Journal of Medicine, 2007
- Medication adherence and health care costs associated with biologics in Medicaid‐enrolled patients with psoriasisJournal of Dermatological Treatment, 2006